Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: SU011248|DRUG: Paclitaxel
Sponsor: Pfizer